ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Supernus Pharmaceuticals Inc. (SUPN) on Tuesday reported a loss of $4.1 million in its fourth quarter.
The Rockville, Maryland-based company said it had a loss of 7 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, were 92 cents per share.
The drugmaker posted revenue of $211.6 million in the period.
For the year, the company reported a loss of $38.6 million, or 68 cents per share. Revenue was reported as $719 million.
Supernus expects full-year revenue in the range of $840 million to $870 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SUPN at https://www.zacks.com/ap/SUPN
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
